What skin examinations are recommended before and during nirogacestat treatment to monitor for non-melanoma skin cancers?

Skin examinations should be performed before starting nirogacestat and routinely during treatment to monitor for non-melanoma skin cancers, including basal cell and squamous cell carcinoma; cases should be managed according to clinical practice, and patients may continue nirogacestat without dose adjustment.